| Literature DB >> 33927623 |
Mahdi Balali-Mood1, Kobra Naseri1, Zoya Tahergorabi1, Mohammad Reza Khazdair2, Mahmood Sadeghi1.
Abstract
The industrial activities of the last century have caused massive increases in human exposure to heavy metals. Mercury, lead, chromium, cadmium, and arsenic have been the most common heavy metals that induced human poisonings. Here, we reviewed the mechanistic action of these heavy metals according to the available animal and human studies. Acute or chronic poisonings may occur following exposure through water, air, and food. Bioaccumulation of these heavy metals leads to a diversity of toxic effects on a variety of body tissues and organs. Heavy metals disrupt cellular events including growth, proliferation, differentiation, damage-repairing processes, and apoptosis. Comparison of the mechanisms of action reveals similar pathways for these metals to induce toxicity including ROS generation, weakening of the antioxidant defense, enzyme inactivation, and oxidative stress. On the other hand, some of them have selective binding to specific macromolecules. The interaction of lead with aminolevulinic acid dehydratase and ferrochelatase is within this context. Reactions of other heavy metals with certain proteins were discussed as well. Some toxic metals including chromium, cadmium, and arsenic cause genomic instability. Defects in DNA repair following the induction of oxidative stress and DNA damage by the three metals have been considered as the cause of their carcinogenicity. Even with the current knowledge of hazards of heavy metals, the incidence of poisoning remains considerable and requires preventive and effective treatment. The application of chelation therapy for the management of metal poisoning could be another aspect of heavy metals to be reviewed in the future.Entities:
Keywords: ROS; acute poisoning; chronic poisoning; heavy metals; mechanistic action; oxidative stress
Year: 2021 PMID: 33927623 PMCID: PMC8078867 DOI: 10.3389/fphar.2021.643972
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Toxic mechanisms of Hg, Pb, Cr, Cd, and As.
| Toxic metal | Organ toxicity | Disrupted macromolecule/mechanism of action | References |
|---|---|---|---|
| Mercury (Hg) | - CNS injuries | - Thiol binding (GSH conjugation) |
|
| - Renal dysfunction | - Enzymes inhibition | ||
| - GI ulceration | - ROS production | ||
| - Hepatotoxicity | - Aquaporins mRNA reduction | ||
| - Glutathione peroxidase inhibition | |||
| - Increased c-fos expression | |||
| Lead (Pb) | - CNS injury | - Increased inflammatory cytokines IL-1β, TNF-α, and IL-6 in the CNS |
|
| - Lungs dysfunction | - Increased serum ET-1, NO, and EPO | ||
| - Hematological changes (Anemia) | - Inactivation of δ-ALAD and ferrochelatase (inhibition of heme biosynthesis) | ||
| - GI colic | - Reduced GSH, SOD, CAT, and GPx levels | ||
| - Liver damage | |||
| - Reduced pulmonary function | |||
| - Cardiovascular dysfunction | |||
| Chromium (Cr) | - Kidney dysfunction | - DNA damage |
|
| - GI disorders | - Genomic instability | ||
| - Dermal diseases | - Oxidative stress and ROS generation | ||
| - Increasing the incidence of cancers including lungs, larynx, bladder, kidneys, testicular, bone, and thyroid | |||
| Cadmium (Cd) | - Degenerative bone disease | - miRNA expression dysregulation |
|
| - Kidney dysfunction | - Apoptosis | ||
| - Liver damage | - Endoplasmic reticulum stress | ||
| - GI disorders | - Cd-MT absorption by the kidneys | ||
| - Lungs injuries | - Dysregulation of Ca, Zn, and Fe homeostasis | ||
| - Disorders in the metabolism of Zn and Cu | - Low serum PTH | ||
| - Cancer | - ROS generation | ||
| - Altered phosphorylation cascades | |||
| Arsenic (As) | - Cardiovascular dysfunction | -Damage of capillary endothelium |
|
| - Skin and hair changes | - Thiol binding (GSH conjugation) | ||
| - CNS injury | - Uncoupler of oxidative phosphorylation (inhibition of ATP formation) | ||
| - GI discomfort | - Alterations in neurotransmitter homeostasis | ||
| - Liver damage |
FIGURE 1Schematic of Pb-induced anemia via the inhibition of δ-aminolevulinic acid dehydratase and ferrochelatase enzymes in heme biosynthesis.
FIGURE 2Oxidative stress and organ toxicity following exposure to heavy metals.
Daily consumption limits for the five heavy metals (μg/day)
| Hg | Pb | Cr | Cd | As | |
|---|---|---|---|---|---|
| A | — | 0.5 | 8.2 | 4.1 | — |
| B | 20 | 20 | — | 6 | 10 |
| C | 21 (inorganic) | — | 210 | 70 | 21 (inorganic) |
| D | 50 | 250 | 120 | 55 | 150 |
| E | 16 | 250 | — | 70 | 150 |
| F | 2 | 10 | — | 4.1 | 10 |
| G | 16 (methyl) | — | 63 (hexavalent) | 25 | 210 |
A, The California Safe Drinking Water and Toxic Enforcement Act (California Proposition 65) maximum allowable dose levels for chemicals causing reproductive toxicity, μg/day; B, American National Standards Institute (ANSI)/International Dietary Supplement Standard 173 = ANSI 173 Guidelines to the Dietary Supplement; C, United States Environmental Protection Agency (EPA) daily reference doses, μg/day; D, The Food and Agricultural Organization/World Health Organization Joint Expert Committee on Food Additives Acceptable Daily Intakes; E, Europe/WHO; F, American Herbal Products Association (AHPA); G, The European Food Safety Authority (EFSA).
A few regulation presented limits as tolerable weekly intake. Such thresholds were considered and shown as the maximum daily exposure in Table 2.
FIGURE 3Simplified schematic presentation of the reaction of Cd metal ion with the thiol functional group; the two sulfhydryl groups are shown in cream color.
FIGURE 4Me-Hg induces PLD activation. Increased PLD activity can lead to many diseases and cancers. Adapted from Brown et al. (2017) .